Annual Report 2023

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2023 125 The United Laboratories International Holdings Limited Annual Report 2023 35. CAPITAL COMMITMENTS 2023 2022 RMB’000 RMB’000 Capital expenditure in respect of the acquisition of property, plant and equipment contracted for but not provided in the consolidated financial statements 989,055 355,691 36. DERIVATIVE FINANCIAL INSTRUMENTS 2023 2022 RMB’000 RMB’000 Foreign currency forward contracts – assets – 1,841 Foreign currency forward contracts – current liabilities (25,587) (10,087) Foreign currency forward contracts – non-current liabilities (19,191) – (44,778) (8,246)